Genvax Technologies: Funding, Investors & Team (Sep 2026)
Genvax Technologies is a newly established company that focuses on developing vaccines for animals.
Genvax Technologies has raised $9.9M across 2 funding rounds on record, the most recent an undisclosed round of $3.4M announced in Jun 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genvax Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Genvax Technologies Funding Rounds
Genvax Technologies raised $6.5M in a Seed announced in Aug 2022.
1.8 years later, an undisclosed round of $3.4M was announced in Jun 2024.
Genvax Technologies Founders and Leadership Team
Contact details for the Genvax Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Genvax Technologies Funding Compared to Other Biotechnology Startups
Genvax Technologies' latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genvax Technologies in Biotechnology and Ames
Companies Similar to Genvax Technologies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Genvax Technologies Funding FAQs
What does Genvax Technologies do?
Genvax Technologies is a newly established company that focuses on developing vaccines for animals.
How much funding has Genvax Technologies raised?
Genvax Technologies has raised $9.9M across 2 rounds on record. The most recent is an undisclosed round of $3.4M announced in Jun 2024.
When did Genvax Technologies last raise funding?
Genvax Technologies' most recent funding round on record is an undisclosed round of $3.4M, announced in Jun 2024.
Who founded Genvax Technologies?
FundedIQ lists Joel Harris (Founder) at Genvax Technologies.
Where is Genvax Technologies headquartered?
Genvax Technologies is based in Ames, Iowa, United States.
How many employees does Genvax Technologies have?
Genvax Technologies is in the 1-10 employee band.
How does Genvax Technologies' funding compare to other Biotechnology startups?
Genvax Technologies' latest round of $3.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Genvax Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genvax Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.